Scientists have identified a promising target for treatment of a devastating autoimmune disease affecting the brain.

The images showed that nearly all the antibodies bind to a single domain of the receptor, providing a viable target for novel therapeutics.

No standard treatments for the sometimes deadly disorder have been developed, but that may change due to the newly published ...

Drugs that act on NMDA (N-methyl-D-aspartate) receptors, which are essential for learning, memory and moment-by-moment consciousness, are key for treating neuropsychiatric disorders. These drugs were ...

A new study suggests a potential molecular strategy for treating fragile X syndrome, an inherited neurodevelopmental disorder that causes autism spectrum disorder and intellectual disability. This ...

OHSU neuroscientists Eric Gouaux, at left, and Junhoe Kim review a detailed representation of the NMDA receptor drawn from cryo-electro microscopic images revealing areas on the receptor likely to be ...

Ben Tarver’s night terrors were the first symptoms of Anti-NMDA Receptor Encephalitis, a rare autoimmune disorder that landed him in the ICU Liam Nougher / SWNS Ben Tarver, 29, began having seizures ...

Researchers from the Institute for Neurosciences (IN), a joint center of the Miguel Hernández University of Elche (UMH) and the Spanish National Research Council (CSIC), who are also part of the ...